Prostate Cancer and The Genetic Marker
Links shared publicly online about this topic.
- 1,437total visits
Prostate Cancer and The Genetic Marker
View full resource at immortalhumans.com
Tags: Genetic, Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on January 22, 2010 at 6:25 pm By:
Prostate Cancer and The Genetic Marker http://bit.ly/7Y5Yq6
Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk
medicalnewstoday.com — “Men who carry the mutated BRCA1 gene have a four times greater chance of developing prostate cancer than other males, researchers from the Institute of Cancer Research and the Royal” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2012 at 8:05 pm By:
Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk http://t.co/rsmr8s0B #prostate
Aggressive Prostate Cancer Risk Linked With Two Genetic Deletions In Human Genome
medicalnewstoday.com — “According to a study published online in Proceedings of the National Academy of Sciences (PNAS), researchers have identified two inherited-genetic deletions in the human genome asso” View full resource at medicalnewstoday.com
Most Recently Shared on April 16, 2012 at 7:05 pm By:
Aggressive Prostate Cancer Risk Linked With Two Genetic Deletions In Human Genome http://t.co/0akWrqUi #prostate
Link Between 2 Genetic Deletions In Human Genome And The Development Of Aggressive Prostate Cancer
medicalnewstoday.com — “An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate c” View full resource at medicalnewstoday.com
Most Recently Shared on April 11, 2012 at 7:06 am By:
Link Between 2 Genetic Deletions In Human Genome And The Development Of Aggressive Prostate Cancer http://t.co/ugauHp4e #prostate
Researchers Identify Genetic Markers Of Drug Sensitivity In Cancer Cells
medicalnewstoday.com — “In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published” View full resource at medicalnewstoday.com
Most Recently Shared on March 29, 2012 at 11:05 am By:
Researchers Identify Genetic Markers Of Drug Sensitivity In Cancer Cells: In the largest study of its kind, rese... http://t.co/HKVW3O7t
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library
www3.interscience.wiley.com — “Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at www3.interscience.wiley.com
Most Recently Shared on March 26, 2012 at 7:00 am By:
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics: (Source: Journal of ... http://t.co/NZgs3x4A
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library
onlinelibrary.wiley.com — “Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics - Hall - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 26, 2012 at 6:26 am By:
Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics: (Source: Journal of ... http://t.co/No2XOoDC
DNA marker predicts platinum drug response in breast, ovarian cancer - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber and Brigham and Women’s researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at dana-farber.org
Most Recently Shared on March 24, 2012 at 10:30 pm By:
Discovery of genetic marker predicting response to platinum drugs in triple-negative #breastcancer http://t.co/IFMrAlTO
Predicting platinum drug response in breast, ovarian cancers - National Cancer Institute
cancer.gov — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-base” View full resource at cancer.gov
Most Recently Shared on March 23, 2012 at 9:20 pm By:
Researchers at @DanaFarber find DNA marker predicts platinum drug response in #breast, #ovarian #cancer http://t.co/whanFNVZ
Genetic marker identifies tumors unable to repair DNA damage by platinum agents
news-medical.net — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 2:58 pm By:
Genetic marker identifies tumors unable to repair DNA damage by platinum agents: Scientists from Brigham and Wom... http://t.co/hCvtHq12
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 4:29 pm By:
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer: Brigham and Women's Hospital and Dana-Farb... http://t.co/6ciU9u4w
DNA marker predicts platinum drug response in breast, ovarian cancer
medicalxpress.com — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive 'triple negative' breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 2:45 pm By:
PhysOrg Health News Health News
DNA marker predicts platinum drug response in breast, ovarian cancer http://t.co/3Uu90Gwq
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:39 pm By:
newswise Health Communicator and Health News
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/Yf75k9xK
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:31 pm By:
#health news: DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/lGmyGKPG
DNA marker predicts platinum drug response in breast, ovarian cancer
eurekalert.org — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies. The marker, found on chromosomes within the cancer cells, flags breast and ovarian cancer cells that can't repair the type of DNA damage caused by treatment with platinum drugs, including cisplatin and carboplatin.” View full resource at eurekalert.org
Most Recently Shared on March 22, 2012 at 2:30 pm By:
From @DanaFarber : #DNA marker predicts platinum drug response in breast, ovarian #cancer. http://t.co/42uuDOZc
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:25 pm By:
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer: Brigham and Women's Hospital and D... http://t.co/65TshQMm #cancer
Advertisement
